CompoAtlas

Ostéocynésine

Natural health product licensed in Canada

Licence holder
Boiron Canada Inc.
NPN or DIN-HM
80022587
Status
Inactive licence
Licence date
1 December 2010
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Homéopathique

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Sulphur iodatum

Source : Iode

4 CHNot calculated

Non-medicinal ingredients

Stéarate de magnésium, Sucrose, Lactose

PopulationAgeQuantity per servingFrequency
Enfantsminimum: 2 years2 Compriméminimum: 2 days ; maximum: 3 days
AdultesNot specified2 Compriméminimum: 2 days ; maximum: 3 days

Uses authorised in Canada

Médicament homéopathique à utiliser pour favoriser la guérison des fractures et soulager les douleurs de croissance chez l'enfant.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80022587

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line